Atlas Trials

Semaglutide 2.4 mg in Patients With Poor Weight-loss

Clinical trial NCT05073835 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT05073835
Sponsor
University College, London
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
ObesityDiabetesMetabolic Syndrome
Start date
2022-11-01
Primary completion
2025-03-01
Enrollment
70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.